Profile Clinico Patological of Leprosy at Prof. Dr. I. G. N. G. Ngoerah Central Hospital Denpasar During 2017 – 2022

Main Article Content

Anak Agung Ayu Mutiara Wikaputri
Herman Saputra
Ni Putu Ekawati
I Wayan Juli Sumadi
Corresponding Author:
Anak Agung Ayu Mutiara Wikaputri | mutiarawika06@gmail.com



Abstract

Introduction: Leprosy is a chronic disease caused by Mycobacterium Leprae. According to the WHO, leprosy is one of the communicable diseases that affect the skin, peripheral nerves, and upper mucosa, and it can cause physical disabilities, if not properly handled. This study aims to determine the clinical and pathological profile of leprosy at Prof. dr. I. G. N. G. Ngoerah Central Hospital Denpasar, in 2017 - 2022. Metods: The study used a descriptive research design with total sampling from secondary data obtained from the Pathology Anatomy Laboratory of Prof. dr. I. G. N. G. Ngoerah Central Hospital Denpasar. The sample collected during the study period included 63 samples of patients diagnosed with leprosy, which were then processed using SPSS software version 26. Result: The highest number of cases was found in patients age group of 19-64 years, accounting for 55 cases (87.3%), predominantly in male patients with 36 cases (57.1%). The most common main complaint was red patches, with 43 cases (72.8%) presenting erythematous skin lesions, specifically plaques, in 24 cases (42.8%). Conclusion: Based on classification, leprosy was more frequently grouped into two classifications: WHO classification and Ridley Jopling classification. According to the WHO classification, the majority of patients were found to have the PB type, accounting for 35 cases (55.6%), while based on the Ridley Jopling classification, the BT type was more prevalent, with 21 cases (33.3%). This study is beneficial as it provides insights into the clinical and pathological profile of leprosy. Further analytical research is needed to explore the relationships between various variables

Article Details

How to Cite
[1]
A. A. A. M. Wikaputri, H. Saputra, N. P. Ekawati, and I. W. J. Sumadi, “Profile Clinico Patological of Leprosy at Prof. Dr. I. G. N. G. Ngoerah Central Hospital Denpasar During 2017 – 2022”, Babali Nurs. Res., vol. 5, no. 1, pp. 230-239, Jan. 2024.
Section
Original Research

References

[1] L. P. V. C. Sari and I. G. K. Darmada, “Prevalensi dan Karakteristik Penderita Reaksi Kusta Tipe 1 di Poliklinik Kulit dan Kelamin RSUP Sanglah Periode Januari - Desember 2014,” E-Jurnal Med., vol. 7, no. 11, pp. 1–5, 2018, [Online]. Available: https://ojs.unud.ac.id/index.php/eum/article/view/44088.
[2] WHO, “LEPROSY.” 2018, [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/leprosy.
[3] R. Mayasari and S. R, “Diagnosis Klinis Morbus Hansen Tipe Mid Borderline (BB) dengan Gambaran Histopatologis Morbus Hansen Tipe Borderline Tuberculoid (BT),” J. Kedokt. Kesehat. Publ. Ilm. Fak. Kedokt. Univ. Sriwij., vol. 6, no. 2, pp. 57–62, 2019, doi: 10.32539/jkk.v6i1.7713.
[4] I. G. N. Darmaputra and P. A. D. Ganeswari, “Peran sitokin dalam kerusakan saraf pada penyakit kusta: tinjuan pustaka,” Intisari Sains Medis, 2018.
[5] L. Makhakhe, “Leprosy review,” South African Fam. Pract., vol. 63, no. 1, pp. 1–6, 2021, doi: 10.4102/SAFP.V63I1.5311.
[6] Siswanto, T. Asrianti, and D. Mulyana, “Neglected Tropical Disease Kusta (Epidemiologi Aplikatif),” Mulawarman Univ. Press, pp. 1–65, 2020.
[7] A. Djuanda, Ilmu Penyakit Kulit Dan Kelamin, Edisi 7. Universitas Indonesia, 2021.
[8] D. M. D. A. . Laberto, “DETEKSI KUSTA SUBKLINIS PADA NARAKONTAK SERUMAH PENDERITA KUSTA MULTIBASILER DI OE-CUSSE TIMOR LESTE,” 2017.
[9] Kemenkes, KUSTA. 2018.
[10] A. Aprizal, L. Lazuardi, and H. Soebono, “Faktor risiko kejadian kusta,” Ber. Kedokt. Masy., vol. 33, no. 9, p. 427, 2017, doi: 10.22146/bkm.25569.
[11] Ismaini, “Manifestasi Klinis Dan Diagnosa Laboratorium Bakteri Penyebab Infeksi Saluran Pencernaan Mycobacterium leprae,” Yayasan Borneo Lestari, 2018.
[12] K. L. Tuturop, N. P. Adimuntja, and D. E. Borlyin, “Faktor Risiko Kejadian Penyakit Kusta di Puskesmas Kotaraja,” Jambura J. Epidemiol., vol. 1, no. 1, pp. 1–10, 2022, doi: 10.37905/jje.v1i1.14622.
[13] I. pd. Aisyah and I. Agusni, “Penelitian Retrospektif: Gambaran Pasien Baru Kusta,” Berk. Ilmu Kesehat. Kulit dan Kelamin, vol. 30, no. 1, pp. 40–47, 2018, [Online]. Available: https://e-journal.unair.ac.id/BIKK/article/view/3814.
[14] Y. Maryen, “faktor resiko kejadian kusta pada anak usia 5-14 tahun di kota sorong papua barat,” no. April, pp. 2000–2016, 2018.
[15] B. Kora, “Faktor Risiko Kejadian Penyakit Kusta Di Wilayah Kerja Puskesmas Saumlaki Kabupaten Maluku Tenggara Barat Tahun 2010-2011,” Media Kesehat. Masy. Indones., vol. 9, no. 4, pp. 236–242, 2016, [Online]. Available: http://journal.unhas.ac.id/index.php/mkmi/article/view/460.
[16] P. Pradana et al., “Gambaran Klinis dan Histopatologi Fenomena Lucio,” Mdvi, vol. 43, no. 4, pp. 147–52, 2016.
[17] D. G. O. Karmila and I. G. A. Dwi, “KUSTA TIPE BORDERLINE LEPROMATOSA DENGAN eritema nodosum leprosum pada pasien yang diduga lupus eritematosus sistematik,” pp. 1–19, 2016.
[18] M. I. Hadi and M. L. F. Kumalasari, Kusta Stadium Subklinis Faktor Risiko dan Permasalahannya. 2017.